Skip to content

Efficacy of Low Dose Propofol Given at the End of Sevoflurane Anesthesia for Prevention of Emergence Agitation in Pediatric Patient Undergoing MRI Scan

Efficacy of Low Dose Propofol Given at the End of Sevoflurane Anesthesia for Prevention of Emergence Agitation in Pediatric Patient Undergoing MRI Scan

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06218680
Enrollment
134
Registered
2024-01-23
Start date
2024-01-20
Completion date
2025-04-30
Last updated
2024-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergence Agitation

Brief summary

The goal of this clinical trial is to compare Efficacy of low dose propofol(0.5 mg/kg) vs placebo given at the end of sevoflurane anesthesia for prevention of emergence agitation in pediatric patient undergoing MRI scan. The main question it aims to answer is Can low dose propofol reduce the incidence of emergence agitation after general anesthesia? Participants will be given propofol 0.5 mg/kg or saline according to the allocated group at the completion of MRI scan

Interventions

DRUGPropofol

recieve propofol 0.5 mg/kg intravenously at end of sevoflurane anesthesia

DRUGNormal saline

recieve propofol 0.5 mg/kg intravenously at end of sevoflurane anesthesia

Sponsors

Khon Kaen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

RCT

Eligibility

Sex/Gender
ALL
Age
1 Years to 8 Years
Healthy volunteers
No

Inclusion criteria

* Age 2-8 years * ASA class I or II ,who schedule for MRI scan under sevoflurane anesthesia

Exclusion criteria

* Developmental delay * Psychological and neurological disorders * Abnormal airway * Reactive airway disease * Allergy to propofol, egg product * Family history of malignant hyperthermia * Need iv sedative medication before induction * Obesity

Design outcomes

Primary

MeasureTime frame
incidence of emergence agitationat 5,10,15,20,25,30 minutes after extubation

Secondary

MeasureTime frameDescription
Length of stay in post anesthetic care unit2 hours after extubation
Incidence of complication2 hours after extubationNausea or vomiting, airway obstruction, laryngospasm, desaturation and apnea
Use of rescue medication2 hours after extubationuse of ondansetron, atropine
Emergence time2 hours after extubationduration of emergence

Countries

Thailand

Contacts

Primary ContactSanthita Pimonbut, M.D.
Santhita.p@kkumail.com66943624641

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026